emavusertib,ibrutinib
janssen,abbvie,curis
['ibru', 'lymphoma', 'emavusertib', '$cris']
$cris takeaim lymphoma data for the combination of emavusertib plus ibrutinib show tumor reduction in 8 of 9 evaluable patients, including 2 crs and 2 prs 2 dlts at 300 mg (non-rhabdo) 
We cannot direct the wind, but we can adjust the sails...  Family Office. Founder Princeton Biomedical Comm., LLC.